1 Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
2 RTI International, Women's Global Health Imperative, San Francisco, California.
AIDS Patient Care STDS. 2019 Apr;33(4):157-166. doi: 10.1089/apc.2018.0177.
Implants are in the pre-clinical stage for long-acting HIV pre-exposure prophylaxis (PrEP), with an opportunity to solicit end-users' feedback early in development. Health care providers (HCPs) have been key gatekeepers for contraceptive implant uptake, and uniquely understand both technical considerations and the social context of use. Given their influential role, we gathered South African HCP perspectives on contraceptive implant implementation and features of PrEP implant prototypes that may influence future provider and patient acceptability. We conducted in-depth interviews with 30 HCPs (20 nurses and 10 doctors) in Cape Town and Soshanguve, South Africa. Interviews were conducted by a bioengineer and later transcribed, coded, and analyzed for key themes. HCPs described health system barriers such as understaffed clinics and inadequate training on contraceptive implant removal as major influences to their PrEP implant design preferences. They preferred a PrEP implant that is long lasting (>6 months) to minimize patient-clinic interactions, biodegradable to avoid need for removal, and flexible (but still palpable in case of removal). Commenting on negative experiences with contraceptive implant rollout, they recommended prioritizing both HCP and community education on the PrEP implant, with emphasis on expected side effects, and planning ahead for adequate training of HCPs before rollout. Challenges experienced with past contraceptive implant rollout may taint perspectives on future PrEP implants and must be carefully considered during product development and planning for clinical studies. Particular consideration should be given to the health system context of future distribution, including staff who would be providing and monitoring implants.
植入物处于长效 HIV 暴露前预防(PrEP)的临床前阶段,有机会在开发早期征求最终用户的反馈意见。医疗保健提供者(HCP)一直是避孕植入物采用的关键把关者,他们独特地了解技术考虑因素和使用的社会背景。鉴于他们的影响力,我们收集了南非 HCP 对避孕植入物实施和 PrEP 植入物原型特征的看法,这些特征可能会影响未来提供者和患者的可接受性。我们在南非开普敦和索萨古夫进行了深入访谈,采访了 30 名 HCP(20 名护士和 10 名医生)。访谈由一名生物工程师进行,然后进行转录、编码和分析关键主题。HCP 描述了卫生系统的障碍,如诊所人手不足和缺乏避孕植入物取出方面的培训,这些都是对他们 PrEP 植入物设计偏好的主要影响因素。他们更喜欢长效(>6 个月)的 PrEP 植入物,以尽量减少患者与诊所的互动,希望植入物可生物降解,避免需要取出,且具有一定的柔韧性(但在取出时仍能感觉到)。在谈到避孕植入物推出的负面经验时,他们建议优先对 HCP 和社区进行 PrEP 植入物的教育,重点是预期的副作用,并在推出前提前计划对 HCP 进行充分的培训。过去避孕植入物推出所面临的挑战可能会影响对未来 PrEP 植入物的看法,在产品开发和临床研究规划阶段必须仔细考虑。特别应考虑未来分配的卫生系统背景,包括提供和监测植入物的工作人员。